Preventive Neurology Unit

  

UNIT LEAD Alastair Noyce

The Preventive Neurology Unit brings together an expert team to carry out revolutionary new research into dementia, Multiple Sclerosis, and Parkinson’s Disease. Their work includes investigating causal pathways, genetic and environmental factors; creation of novel clinical cohorts and development of new tests; and exploring whether simple interventions can prevent or delay the onset of these disorders.

The Unit was formed in 2017 following investment from Barts Charity and has grown rapidly within the Wolfson Institute. Substantial additional funding has been awarded from the NIHR, MRC, UK MS Society, Parkinson’s UK, NMSS, Cure Parkinson’s, BMA Foundation and the Aligning Science Across Parkinson’s Initiative. Established collaborations include GP2, IPDGC, 23andMe UCL, and Imperial College.

• Neurological disease – main areas of interest dementia, MS and PD.
  
  
• Traditional epidemiology.
  
  
• Genetic epidemiology.
  
  
• Clinical cohort creation.
  
  
• Under-represented populations.
  
  
• Real world and health records data.
  
  
• Patient and public involvement.
  
  
• Imaging and laboratory biomarkers.
  
  

OUR TEAM 

Dr. Ruth Dobson

Dr. Charles Marshall

Dr. Alastair Noyce

Mr. Jonathan Bestwick

Dr. Alison Thomson

 

CONTACT

Charterhouse Square

Olivia Downey, o.downey@qmul.ac.uk